Literature DB >> 17392267

Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesis.

Nadia F Lamour1, Robert V Stahelin, Dayanjan S Wijesinghe, Michael Maceyka, Elaine Wang, Jeremy C Allegood, Alfred H Merrill, Wonhwa Cho, Charles E Chalfant.   

Abstract

Ceramide kinase (CERK) is a critical mediator of eicosanoid synthesis, and its product, ceramide-1-phosphate (C1P), is required for the production of prostaglandins in response to several inflammatory agonists. In this study, mass spectrometry analysis disclosed that the main forms of C1P in cells were C(16:0) C1P and C(18:0) C1P, suggesting that CERK uses ceramide transported to the trans-Golgi apparatus by ceramide transport protein (CERT). To this end, downregulation of CERT by RNA interference technology dramatically reduced the levels of newly synthesized C1P (kinase-derived) as well as significantly reduced the total mass levels of C1P in cells. Confocal microscopy, subcellular fractionation, and surface plasmon resonance analysis were used to further localize CERK to the trans-Golgi network, placing the generation of C1P in the proper intracellular location for the recruitment of cytosolic phospholipase A(2)alpha. In conclusion, these results demonstrate that CERK localizes to areas of eicosanoid synthesis and uses a ceramide "pool" transported in an active manner via CERT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392267     DOI: 10.1194/jlr.M700083-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  41 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

2.  Lateral Segregation of Palmitoyl Ceramide-1-Phosphate in Simple and Complex Bilayers.

Authors:  Md Abdullah Al Sazzad; Tomokazu Yasuda; Thomas K M Nyholm; J Peter Slotte
Journal:  Biophys J       Date:  2019-05-21       Impact factor: 4.033

3.  Phosphoregulation of the ceramide transport protein CERT at serine 315 in the interaction with VAMP-associated protein (VAP) for inter-organelle trafficking of ceramide in mammalian cells.

Authors:  Keigo Kumagai; Miyuki Kawano-Kawada; Kentaro Hanada
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

Review 4.  Lipidomics in translational research and the clinical significance of lipid-based biomarkers.

Authors:  Daniel J Stephenson; L Alexis Hoeferlin; Charles E Chalfant
Journal:  Transl Res       Date:  2017-06-15       Impact factor: 7.012

Review 5.  An overview of sphingolipid metabolism: from synthesis to breakdown.

Authors:  Christopher R Gault; Lina M Obeid; Yusuf A Hannun
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

6.  Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5.

Authors:  Benjamin Newcomb; Cosima Rhein; Izolda Mileva; Rasheed Ahmad; Christopher J Clarke; Justin Snider; Lina M Obeid; Yusuf A Hannun
Journal:  J Lipid Res       Date:  2018-05-03       Impact factor: 5.922

7.  Chain length specificity for activation of cPLA2alpha by C1P: use of the dodecane delivery system to determine lipid-specific effects.

Authors:  Dayanjan S Wijesinghe; Preeti Subramanian; Nadia F Lamour; Luciana B Gentile; Maria H Granado; Alicja Bielawska; Zdzislaw Szulc; Antonio Gomez-Munoz; Charles E Chalfant
Journal:  J Lipid Res       Date:  2008-12-15       Impact factor: 5.922

Review 8.  Sphingolipids in mitochondria.

Authors:  María José Hernández-Corbacho; Mohamed F Salama; Daniel Canals; Can E Senkal; Lina M Obeid
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-30       Impact factor: 4.698

9.  A fluorescent plate reader assay for ceramide kinase.

Authors:  Anthony S Don; Hugh Rosen
Journal:  Anal Biochem       Date:  2007-12-25       Impact factor: 3.365

Review 10.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.